AMA
Rejdak R, Szkaradek M, Taslaq W, Kałużny JJ, Grieb P, Jünemann AG. New drug VEGF Trap-Eye – Eylea – and its use in the treatment of age-related
macular degeneration, central retinal vein occlusion, diabetic macular edema,
and choroidal neovascularization secondary to pathologic myopia. Klinika Oczna / Acta Ophthalmologica Polonica. 2012;114(4):308-310.
APA
Rejdak, R., Szkaradek, M., Taslaq, W., Kałużny, J. J., Grieb, P., & Jünemann, A. G. (2012). New drug VEGF Trap-Eye – Eylea – and its use in the treatment of age-related
macular degeneration, central retinal vein occlusion, diabetic macular edema,
and choroidal neovascularization secondary to pathologic myopia. Klinika Oczna / Acta Ophthalmologica Polonica, 114(4), 308-310.
Chicago
Rejdak, Robert, Małgorzata Szkaradek, Wesam Taslaq, Jakub J Kałużny, Paweł Grieb, and Anselm G Jünemann. 2012. "New drug VEGF Trap-Eye – Eylea – and its use in the treatment of age-related
macular degeneration, central retinal vein occlusion, diabetic macular edema,
and choroidal neovascularization secondary to pathologic myopia". Klinika Oczna / Acta Ophthalmologica Polonica 114 (4): 308-310.
Harvard
Rejdak, R., Szkaradek, M., Taslaq, W., Kałużny, J., Grieb, P., and Jünemann, A. (2012). New drug VEGF Trap-Eye – Eylea – and its use in the treatment of age-related
macular degeneration, central retinal vein occlusion, diabetic macular edema,
and choroidal neovascularization secondary to pathologic myopia. Klinika Oczna / Acta Ophthalmologica Polonica, 114(4), pp.308-310.
MLA
Rejdak, Robert et al. "New drug VEGF Trap-Eye – Eylea – and its use in the treatment of age-related
macular degeneration, central retinal vein occlusion, diabetic macular edema,
and choroidal neovascularization secondary to pathologic myopia." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 114, no. 4, 2012, pp. 308-310.
Vancouver
Rejdak R, Szkaradek M, Taslaq W, Kałużny J, Grieb P, Jünemann A. New drug VEGF Trap-Eye – Eylea – and its use in the treatment of age-related
macular degeneration, central retinal vein occlusion, diabetic macular edema,
and choroidal neovascularization secondary to pathologic myopia. Klinika Oczna / Acta Ophthalmologica Polonica. 2012;114(4):308-310.
